Sumitomo Pharma Co., Ltd. (TYO:4506)
1,895.50
+2.00 (0.11%)
Nov 20, 2026, 9:04 AM JST
Sumitomo Pharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Sumitomo Pharma stock has a consensus rating of "Buy" and an average price target of ¥2,243. The average 1-year stock price forecast is 18.33% higher than the current stock price, while the lowest is ¥1,500 (-20.87%) and the highest is ¥2,800 (+47.72%).
Price Target: ¥2,243 (+18.33%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 14, 2026.
Analyst Ratings
The average analyst rating for Sumitomo Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ¥2,400 → ¥2,700 | Buy | Maintains | ¥2,400 → ¥2,700 | +42.44% | Sep 14, 2026 |
| Citi | Citi | Sell Maintains ¥1,500 | Sell | Maintains | ¥1,500 | -20.87% | May 26, 2026 |
Financial Forecast
Revenue This Year
559.10B
from 453.29B
Increased by 23.34%
Revenue Next Year
615.06B
from 559.10B
Increased by 10.01%
EPS This Year
191.95
from 268.99
Decreased by -28.64%
EPS Next Year
220.17
from 191.95
Increased by 14.70%
Financial currency is JPY.